1979
DOI: 10.1038/281317a0
|View full text |Cite
|
Sign up to set email alerts
|

1α, 25-Dihydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
160
1
5

Year Published

1994
1994
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 337 publications
(173 citation statements)
references
References 13 publications
4
160
1
5
Order By: Relevance
“…By contrast, serum levels of 1,25(OH) 2 D increase by approximately twofold during the first trimester, and peak during the third trimester (Brannon & Picciano 2011). Renal synthesis of 1,25(OH) 2 D by the mother plays a key role in this elevation of maternal serum 1,25(OH) 2 D levels, but as outlined above, there is also evidence of local 1,25(OH) 2 D generation in both the placenta (fetal) and decidua (maternal) (Gray et al 1979, Weisman et al 1979. Early in pregnancy, the maternal decidua and fetal trophoblast cells show induced expression of both VDR and 1a-hydroxylase (CYP27B1), the enzyme that catalyses conversion of 25OHD to 1,25(OH) 2 D. By contrast, the vitamin D catabolic enzyme, 24-hydroxylase (CYP24A1), shows decreased expression in placental/decidual tissues across gestation (Zehnder et al 2002, Evans et al 2004.…”
Section: Vitamin D and Human Pregnancymentioning
confidence: 93%
See 1 more Smart Citation
“…By contrast, serum levels of 1,25(OH) 2 D increase by approximately twofold during the first trimester, and peak during the third trimester (Brannon & Picciano 2011). Renal synthesis of 1,25(OH) 2 D by the mother plays a key role in this elevation of maternal serum 1,25(OH) 2 D levels, but as outlined above, there is also evidence of local 1,25(OH) 2 D generation in both the placenta (fetal) and decidua (maternal) (Gray et al 1979, Weisman et al 1979. Early in pregnancy, the maternal decidua and fetal trophoblast cells show induced expression of both VDR and 1a-hydroxylase (CYP27B1), the enzyme that catalyses conversion of 25OHD to 1,25(OH) 2 D. By contrast, the vitamin D catabolic enzyme, 24-hydroxylase (CYP24A1), shows decreased expression in placental/decidual tissues across gestation (Zehnder et al 2002, Evans et al 2004.…”
Section: Vitamin D and Human Pregnancymentioning
confidence: 93%
“…As 25OHD is the principal marker of vitamin D 'status' in any given individual, this has raised the question as to how vitamin D sufficiency or deficiency may affect tissues in which there is significant metabolism of 25OHD. Prominent among these tissues is the placenta, where both fetal and maternal tissues have been shown to synthesise 'active' 1,25(OH) 2 D (Gray et al 1979, Weisman et al 1979.…”
Section: Vitamin D and Human Pregnancymentioning
confidence: 99%
“…More than 30 y ago, the placenta was identified as a major site for conversion of 25OHD to the active form of vitamin D, 1,25-dihydroxyvitamin D 3 (1,25[OH] 2 D 3 ), with both maternal decidua and fetal trophoblast demonstrating activity of the enzyme 1a-hydroxylase (CYP27B1) (7,8). However, since then, the precise function of this extrarenal CYP27B1 has remained unclear.…”
mentioning
confidence: 99%
“…Historically, the placenta was one of the first of these extra-renal tissues shown to be capable of synthesizing 1,25(OH) 2 D, with CYP27B1 activity being detectable in both maternal decidua and fetal trophoblast. 26,27 Since then we have characterized the spatio-temporal organization of placental CYP27B1 and VDR across gestation, confirming that the enzyme and receptor are localized to both the maternal decidua and fetal trophoblast. Significantly, both proteins are more abundant in 1 st and 2 nd trimester tissue.…”
Section: Vitamin D and Human Pregnancy 69mentioning
confidence: 63%